A multicenter, open label extension study to evaluate the safety of twice daily oral carvedilol in pediatric patients with chronic heart failure
Phase of Trial: Phase III
Latest Information Update: 02 Oct 2006
At a glance
- Drugs Carvedilol (Primary)
- Indications Chronic heart failure
- Focus Adverse reactions
- 02 Oct 2006 New trial record.